DSIP stands for delta sleep-inducing peptide, and the name is a promise the science has never fully kept. It is a small peptide — nine amino acids — first pulled from the blood of sleeping rabbits in 1977 and named for its apparent power to bring on delta waves, the slow brain waves of deep sleep. Decades later, it is one of the more honest teaching cases in the peptide world: an intriguing idea whose evidence stayed thin.
In plain terms: an old, small, unresolved sleep peptide — interesting history, weak proof.
What it is
DSIP is a nonapeptide, meaning it is made of nine amino acids strung together (its sequence is Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu). It was isolated in 1977 by the Schoenenberger–Monnier group in Basel, who took blood from the brain circulation of rabbits given gentle electrical stimulation that induced sleep, and tracked the sleep-promoting activity down to this one small peptide1.
That is a genuinely elegant discovery. The trouble is what came — or didn’t come — next.
How it is thought to work
Here is the striking part: after nearly five decades, no one has confirmed how DSIP works. No DSIP receptor has been identified. No DSIP gene has been isolated. A widely cited 2006 review summed the situation up in its title, calling DSIP a "still unresolved riddle"2. It also noted that the peptide is found in the body in a "free" form and is rapidly broken down, which complicates the whole picture.
In plain terms: we have a peptide and a name, but not a mechanism. When a compound has been studied this long without a confirmed receptor, that absence is itself important information.
Pharmacokinetics and half-life
DSIP is short-lived. In the body it is degraded quickly by enzymes (a specific aminopeptidase has been described that breaks it down), so it does not persist in the blood for long2. Its plasma half-life is measured in minutes, not hours — which is one reason its effects have been hard to pin down and reproduce.
What the studies actually found
The DSIP literature is mostly old and mostly small. Some early human studies were encouraging; the field simply never built the large, modern trials that would confirm them. Note the level and size in each row.
| Study (cited) | Model / level | Key result | Year |
|---|---|---|---|
| Schoenenberger, Monnier et al.1 | Rabbit + peptide chemistry | Isolated and sequenced the nonapeptide; reported sleep-promoting activity | 1977 |
| Larbig et al. — pilot3 | Human, n=7 (chronic pain) | 6 of 7 patients had reduced pain after intravenous DSIP; a small, uncontrolled pilot | 1984 |
| Kovalzon & Strekalova — review2 | Review | Concluded the DSIP–sleep link was never firmly established; no receptor or gene found | 2006 |
The pattern is the honest story: a handful of small, mostly 1980s human studies — some reporting sleep, pain, or withdrawal benefits — sitting next to a 2006 review that found the core sleep claim unproven and the mechanism unknown. The pain pilot involved just seven patients and had no placebo control3; results that small and that old cannot carry much weight.
In plain terms: encouraging anecdotes from decades ago, never confirmed by the kind of trial that would settle it.
The honest catch
This is the section that matters most for DSIP. Its evidence base is old, small, and inconsistent, and it has essentially stopped growing. Positive early reports were never replicated at scale; objective sleep-lab measures did not always match the subjective reports; and the total absence of a confirmed receptor after 50 years is a real red flag, not a footnote. DSIP is a research compound, not an approved sleep aid, and this page describes what studies reported — not how to use anything.
Latest research
- There is little genuinely new. DSIP is a rare case where the most useful recent source is a review that steps back and says the evidence never firmed up2. That candour is the point.
- No modern controlled sleep trials. The large, placebo-controlled sleep studies that would confirm or refute the 1970s–80s reports have not been done, so the picture in 2026 is essentially the picture from decades ago.
- The mechanism gap persists. No confirmed DSIP receptor or gene has emerged, which keeps any explanation of how it works speculative.
The short version
DSIP is a nine-amino-acid peptide isolated in 1977 and named for its apparent link to deep, slow-wave sleep1. But its human evidence is old, small, and mixed, its plasma half-life is minutes, and after nearly 50 years no receptor or mechanism has been confirmed — a review called it a "still unresolved riddle"2. It is a research compound, not an approved sleep medicine. Educational overview only. For context, see what are research peptides.